While challenges remain in malaria control towards elimination, new guidelines and recently
approved vaccines offer hope. Monitoring for continued vaccine and chemoprevention …

While two Plasmodium falciparum circumsporozoite protein-based pre-erythrocytic vaccines
(PEV), RTS, S and R21, have been approved by the WHO, no blood-stage vaccine (BSV) or …

Two malaria transmission-blocking vaccine (TBV) candidates, R0. 6C and ProC6C, have
completed preclinical development including the selection of adjuvants, Alhydrogel® with or …

Clinical immunity to malaria develops slowly after repeated episodes of infection and
antibodies are essential in naturally acquired immunity against malaria. However, chronic …

Objectives This study aimed to investigate the clinical and biochemical profiles of patients
with imported malaria infection between 1 January 2011 and 30 April 2022 and admitted to …

Malaria infections in school-age children further make it difficult to control the disease's
spread. Moreover, the genetic diversity of glutamate-rich protein, potentially a candidate for …

Africa bears the greatest burden of malaria with more than 200 million clinical cases and
more than 600,000 deaths in 2020 alone. While malaria-associated deaths dropped steadily …

In 2007, the aim to eradicate malaria was revived and reinvigorated, taking into account the
experiences and lessons of the earlier efforts initiated in the mid 1950's. In particular, it was …